To find out efficacy of 50 Millesimal potency in cases of leucorrhea
Phase 1
- Conditions
- Health Condition 1: B955- Unspecified streptococcus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2023/08/056797
- Lead Sponsor
- Parul Institute Of Homoeopathy And Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age Group of 18-45 Female
-Cases leucorrhea only
Exclusion Criteria
Patients on homoeopathic treatment for any other chronic diseases will be excluded.
Antenatal & postnatal females
Patients having any other chronic degenerative diseases
Patient having Severe PID or any pelvic pathology.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcomes of the study will be measured in terms of clinical signs - per vaginal examination and symptoms <br/ ><br>Pap smear test in required cases <br/ ><br>microbiological improvement. <br/ ><br>amount of discharge <br/ ><br>duration of interval <br/ ><br>itching or notTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method To evaluate the safety tolerability of the formulation in patient suffering from LeucorrheaTimepoint: 4 weeks